Published in

BioMed Central, BMC Pulmonary Medicine, 1(22), 2022

DOI: 10.1186/s12890-022-01862-x

Links

Tools

Export citation

Search in Google Scholar

Central airway obstruction: is it time to move forward?

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractIntroductionCentral airway obstruction (CAO) represents a pathological condition that can lead to airflow limitation of the trachea, main stembronchi,bronchus intermediusorlobar bronchus.Main bodyIt is a common clinical situation consensually considered under-diagnosed. Management of patients with CAO can be difficult and deciding on the best treatment approach represents a medical challenge. This work intends to review CAO classifications, causes, treatments and its therapeutic limitations, approaching benign and malign presentations. Three illustrative cases are further presented, supporting the clinical problem under review.ConclusionManagement of CAO still remains a challenge. The available options are not always effective nor free from complications. A new generation of costume-tailored airway stents, associated with stem cell-based therapy, could be an option in specific clinical situations.